SIGANasdaq

SIGA TECHNOLOGIES INC

Healthcare·Oncology·Commercial·New York, NY, United States
OncologyImmunologyGastroenterology

SIGA TECHNOLOGIES INC (SIGA): 4 pipeline candidates · 1 upcoming catalyst · ~57 mo cash runway · 3 clinical trials. Updated within the last hour.

7.7/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway10.0

57.3 months

Financial Health9.3

D/E 0.45 · 0% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth7.2

4 candidates

Catalyst Momentum2.0

1 upcoming, next in ~2243d

Insider SignalN/A

N/A

A transparent, data-derived signal for SIGA TECHNOLOGIES INCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$311.3M

Cash

$145.6M

Quarterly Burn

$8.7M

Runway

57.3 mo

Revenue

$6.2M

Cash Runway vs Catalysts

A catalyst falls after projected cash runway — potential financing / dilution risk before it hits.

Cash ends ~Mar 2031
Today~81 mo out
Catalyst within runwayCatalyst after cash runs out

Pipeline (4 candidates)

Upcoming Catalysts (1)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

181

Total value held

$175.2M

HolderSharesValue
blackrock, inc.3,494,193$18.7M
vanguard capital management llc3,428,760$18.3M
dimensional fund advisors lp2,702,724$14.5M
arrowstreet capital, limited partnership1,525,960$8.2M
american century companies inc1,317,784$7.1M
geode capital management, llc1,315,545$7.0M
aqr capital management llc1,219,677$6.5M
state street corp1,011,938$5.4M
first wilshire securities management inc890,498$4.8M
hotchkis & wiley capital management llc827,047$4.4M

Showing top 10 of 181 institutional holders of SIGA TECHNOLOGIES INC. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

3 clinical trials·2 FDA decisions·CEO: Dr. Diem Nguyen M.B.A., Ph.D.

Frequently asked questions

How many drug candidates are in SIGA TECHNOLOGIES INC's pipeline?

SIGA TECHNOLOGIES INC (SIGA) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is SIGA TECHNOLOGIES INC's lead drug candidate?

SIGA TECHNOLOGIES INC's most advanced tracked candidate is iv tpoxx (Approved) for Smallpox.

What is SIGA TECHNOLOGIES INC's next catalyst?

SIGA TECHNOLOGIES INC's next tracked catalyst is a Patent_Expiry event — "Patent/Exclusivity Expiry: TPOXX" — expected August 8, 2032.

What is SIGA TECHNOLOGIES INC's cash runway?

Based on its most recent reported cash balance and quarterly burn rate, SIGA TECHNOLOGIES INC has approximately 57.3 months of cash runway.

What is SIGA TECHNOLOGIES INC's market capitalization?

SIGA TECHNOLOGIES INC's market capitalization is approximately $311.3M.

Get the full picture on SIGA TECHNOLOGIES INC

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.